Adverse Events of Lutetium-177-PSMA-617 Revealed
Lutetium-177-PSMA-617 (Pluvicto®) has emerged as a groundbreaking radiolabeled therapeutic agent in the battle against advanced prostate cancer, specifically targeting metastatic ...
Tag: prostate-specific membrane antigen targeting
Radiopharmaceutical Combined with Stereotactic Radiation Slows Progression of Oligometastatic Prostate Cancer
A groundbreaking clinical investigation has revealed a transformative approach in the management of recurrent prostate cancer presenting with limited metastatic ...
Innovative Tracer Lets Surgeons Visualize and Hear Prostate Cancer
In the continuous quest to enhance precision in cancer surgeries, a groundbreaking development has emerged from the University of British ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!